Vyaghri Haritaki Avaleha for Cough in children.

Evaluation of Vyaghri Haritaki in management of Kasa Shwasa of children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/014319

Enrollment

Registered

2018-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- 1.Patients of both sex and age range from 1 year to 12 years. 2. Patients suffering from cough due to any cause except exclusion criteria. 3. Those have not received any medicine for last 24 hours.

Interventions

Intervention1: Vyaghri Haritaki Avaleha: 150 mg/kg/dose every 6 hour, orally for seven days Control Intervention1: Not Applicable: Not Applicable

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of both sex and age range from 1 year to 12 years. 2. Patients suffering from cough due to any cause except exclusion criteria. 3. Those have not received any medicine for last 24 hours.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: Patients suffering from- 1. any associated life-threatening disease including aspiration syndrome, emphysema, pneumothorax 2. any congenital anomaly related to respiratory or cardiovascular system. 3. bronchial asthma, empyema, pneumonia or pulmonary TB

Design outcomes

Primary

Measure	Time frame
Improvement in scoring system of KasaTimepoint: 1.At time of case registration 2.On 7th day of treatment 3. On 14th day of treatment	—

Secondary

Measure	Time frame
Any adverse eventTimepoint: After 7th and 14th day	—

Countries

India

Contacts

Public ContactDeepshikha

hodkb2006@yahoo.in9415286910

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026